About us

We are a Business Finland funded Åbo Akademi University Research to Business (R2B) project. We have a strong team, and we are highly committed to making mitochondria delivery a success story.

Our team

has developed an encapsulation technology called COMITELL® for mitochondria.

COMITELL® is an effective and unique approach that can maintain the mitochondria bioactivity for up to four weeks and significantly improve the intracellular delivery efficiency, which has not been achieved before. The encapsulation technology can be used for mitochondria transplantation/delivery therapy for treating the broad scope of mitochondrial-related diseases.

We are ambitious, and our extensive knowledge of biotechnology, pharmaceuticals, and commercialization will ensure a broad perspective this project may open.